Infection Control and Hospital Epidemiology Publication Info
For individual subscriptions, please contact the The University of Chicago Press
University of Chicago Press Customer Service:
1.877.705.1878 (toll-free, U.S. & Canada)
1.773.753.3347 (international)
subscriptions@press.uchicago.edu
For information about institutional access to this title, please visit the Institutional Subscriptions page.
Infection Control Recommendations for Patients with Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient‐To‐Patient Transmission
Formats Available in JSTOR: PDF
Abstract(back to top)
EXECUTIVE SUMMARY. Infection Control Recommendations for Patients With Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient‐to‐Patient Transmission updates, expands, and replaces the consensus statement, Microbiology and Infectious Disease in Cystic Fibrosis published in 1994.1 This consensus document presents background data and evidence‐based recommendations for practices that are intended to decrease the risk of transmission of respiratory pathogens among CF patients from contaminated respiratory therapy equipment or the contaminated environment and thereby reduce the burden of respiratory illness. Included are recommendations applicable in the acute care hospital, ambulatory, home care, and selected non‐healthcare settings. The target audience includes all healthcare workers who provide care to CF patients. Antimicrobial management is beyond the scope of this document.
Bibliographic Information(back to top)
- Infection Control Recommendations for Patients with Cystic Fibrosis: Microbiology, Important Pathogens, and Infection Control Practices to Prevent Patient‐To‐Patient Transmission
- Lisa Saiman , MD, MPH and Jane Siegel , MD
- Infection Control and Hospital Epidemiology
- Vol. 24, No. S5 (May 2003) (pp. S6-S52)
Notes and References(back to top)
This item contains 1 note(s).
Notes
Dr. Saiman is from the Department of Pediatrics, Columbia University, New York, New York. Dr. Siegel is from the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.Address reprint requests to Cystic Fibrosis Foundation, 6931 Arlington Road, Bethesda, MD 20814; telephone: (800) FIGHT-CF; website: www.info@cff.org.The authors thank Sherrie Myers and Elizabeth Garber for their assistance in the preparation of this document.This material is being published simultaneously in Infection Control and Hospital Epidemiology and the American Journal of Infection Control. Copyright SLACK Incorporated.
Items Citing this Item (back to top)
2 item(s) in JSTOR cite this item
- Carolina Marzuillo , BS; Maria De Giusti , BS; Daniela Tufi , BS; Alessandra Giordano , BS; Angela Del Cimmuto , BS; Serena Quattrucci , MD; Carlo Mancini , MD; Paolo Villari , MD, MPHVol. 30, No. 8 (August 2009) pp. 753-758Stable URL: http://www.jstor.org/stable/10.1086/598683
- Ralf‐Peter Vonberg , MD; Petra Gastmeier , MDVol. 26, No. 4 (April 2005) pp. 401-409Stable URL: http://www.jstor.org/stable/10.1086/502558